Hammons Terry
SEC CIK 1801393 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SHC | Sotera Health Co | SVP, GC, Sec | 31.3K | — | — | 2 | 2021-11-11 | 2022-03-02 |
Most active insiders at SHC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WARBURG PINCUS & CO. | Dir, 10% | — | $579.51M |
| 2 | Warburg Pincus Partners II, L.P. | Dir, 10% | — | $510.75M |
| 3 | Warburg Pincus Partners GP LLC | Dir, 10% | — | $387.78M |
| 4 | GTCR FUND XI/A LP | Dir, 10% | — | $293.62M |
| 5 | Warburg Pincus Private Equity XI-C, L.P. | Dir, 10% | — | $281.70M |
| 6 | GTCR INVESTMENT XI LLC | Dir, 10% | — | $193.17M |
| 7 | WARBURG PINCUS LLC | Dir, 10% | — | $158.73M |
| 8 | GTCR CO-INVEST XI LP | Dir, 10% | — | $152.70M |
| 9 | Petras Michael B. Jr. | Executive COB, Dir | — | $33.51M |
| 10 | Rutz Michael P | Pres of Sterigenics | — | $2.83M |
Hammons Terry made no open-market trades at SHC in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-04 | 2022-03-02 | SHC | Sotera Health Co | Hammons Terry | SVP, GC, Sec | A - Grant | $0.00 | +22.5K | 31.3K | +256% | $0 |
| D | 2021-11-12 | 2021-11-11 | SHC | Sotera Health Co | Hammons Terry | SVP, GC, Sec | A - Grant | $0.00 | +8,791 | 8,791 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations